Sagimet Biosciences Appoints Andreas Grauer as Chief Medical Officer
Sagimet Biosciences (SGMT) announced the appointment of Andreas Grauer, MD, as Chief Medical Officer, effective April 20, 2026. Sagimet's prior Chief Medical Officer, Eduardo Bruno Martins, MD, DPhil, who will continue to support the Company as an external scientific advisor, has retired effective April 20, 2026. Grauer most recently served as Chief Medical Officer at Omeros Corporation (OMER)